Preliminary test of group acceptance and commitment therapy on obsessive-compulsive disorder for patients on optimal dose of selective serotonin reuptake inhibitors
| Autor: | Fatemeh Sadat Ghoreishi, Eric B. Lee, Farzaneh Rohani, Hossein Akbari, Morad Rasouli-Azad, Michael P. Twohig |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Clinical interview
050103 clinical psychology medicine.medical_specialty Dose digestive oral and skin physiology 05 social sciences Serotonin reuptake behavioral disciplines and activities Acceptance and commitment therapy humanities 030227 psychiatry 03 medical and health sciences Psychiatry and Mental health Clinical Psychology 0302 clinical medicine Obsessive compulsive mental disorders medicine 0501 psychology and cognitive sciences Psychology Self report Psychiatry Depression (differential diagnoses) |
| Zdroj: | Journal of Obsessive-Compulsive and Related Disorders. 16:8-13 |
| ISSN: | 2211-3649 |
| DOI: | 10.1016/j.jocrd.2017.10.002 |
| Popis: | The aim of this study was to investigate the effects of adding group acceptance and commitment therapy (ACT) to adults diagnosed with obsessive compulsive disorder (OCD) who were already on an optimal dose of selective serotonin reuptake inhibitors (SSRIs). Forty-six Iranian women, on SSRIs, were randomized to group ACT + SSRI or continued SSRI conditions. SSRI dosages stayed stable during the study. Assessments included the Structured Clinical Interview (SCID-I), Yale-Brown Obsessive-Compulsive Scale Self report (Y-BOCS-SR), Beck Depression Inventory-II (BDI-II), Ruminative Response Scale (RRS), and Acceptance and Action Questionnaire (AAQ-II). The results showed significant reductions on the Y-BOCS-SR and BDI-II in both conditions at posttreatment with significantly greater reductions in the ACT + SSRI condition at follow-up. The RRS and AAQ-II saw significant improvements in the ACT + SSRI condition at posttreatment and follow-up compared to the SSRI condition. Results provide cross-cultural support for group ACT as a treatment for OCD and as a successful adjunct to SSRI treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect